Myristol for Equine Joint Pain
Joint disease and osteoarthritis in horses can be game changers, not only for elite performance animals but also for recreational mounts when stiffness, soreness, and lameness interfere with so many activities.
Many therapies target symptom modifications to control pain, but in more recent years a growing number of horse owners prefer a preventative approach to avoid joint issues for their horses with the use of oral nutraceutical supplements.
In 2003, Dr. Gayle W. Trotter, internationally recognized equine surgeon and researcher on lameness and joint issues, founded Myristol Enterprises, LLC, and developed the product, Myristol, for the treatment and prevention of joint injury and disease. He brought to the enterprise not only his professional surgical experience but his competitive years of riding cutting horses. He quickly came to the realization that the competitive sports put a lot of wear and tear on the joints of all equine athletes.
There was clearly a need for a supplement to enhance prevention of joint injury, which would be far more advantageous than having to treat the horse on a surgical table. The result of his research into the most promising ingredients was Myristol.
Myristol can play a major role as a preventive supplement to mitigate joint health challenges and help keep the athletic horse in top form. Photo: Canstock/Jarih
The formulation of Myristol is based on scientific innovation. One of the active ingredients is cetyl myristoleate (CM) derived from beef tallow. It is a unique Omega-5 fatty acid that targets soft tissue inflammation. The tallow provides 40 percent active ingredients compared to approximately 15 percent active ingredients from plant-sourced CM. In addition, another ingredient is hydrolyzed collagen, which comes from porcine (pig) skin. It is an amino acid blend acting as a building block for articular cartilage health. Glucosamine supports the formation of cartilage, and Methylsulfonylmethane (MSM) is a sulfur-based building block that supports the cartilage formation and helps relieve muscle pain.
Myristol is administered as an alfalfa-based pellet, which is top-dressed over concentrate feed. There are no known side effects, no known toxicities, and the product has no known problems with pregnancy or fertility. Positive results usually show within three weeks and many animals, especially older horses, may show improvement within a week. The product also has an application for dogs and humans.
While Myristol is effective in helping animals already affected with joint disease, it can play a major role when given to young, active athletes as a preventive supplement when it may mitigate numerous joint health challenges before serious issues set in, keeping the horse in the athletic game.
Dr. Trotter, though, wanted a science based, double-blind study to put the product to the test.
A randomized, double-blinded, placebo-controlled clinical trial was conducted in 2007 on 39 horses from Missouri and Florida. They were all enrolled after a physical and lameness evaluation by an ACVS (American College of Veterinary Surgeons) surgeon. The horses were selected from four sources – a broodmare farm, a Thoroughbred retirement centre, and two local college/university equestrian programs. To be enrolled in the study, each horse had to have a diagnosis of naturally occurring osteoarthritis and an AAEP (American Association of Equine Practitioners) lameness score between 2 and 4.
They were divided into two groups, one being fed the placebo pelleted mix and the other being fed the supplement Myristol pellet. Both groups remained on the additives for 42 days (all of them consuming their supplements without hesitation) and were assessed on day 0, 14, 28, and 42 after treatment.
It was found that the horses in the Myristol group improved significantly more than the horses in the placebo group, supporting the claim that Myristol had beneficial clinical effects on horses with naturally occurring osteoarthritis. In addition, both variables relating to joint flexion were significantly different between the horses on Myristol compared to the horses in the placebo treated group on all the days they were assessed.
Clearly, Myristol provided marked beneficial effects relating to joint flexion. Reducing pain to passive flexion and lameness after flexion are considered positive clinical effects for horses with osteoarthritis.
The product is available as Myristol and Myristol Pro. Myristol Pro contains an antioxidant mix Promutase 200, which targets horses that tend to get muscle sore or are prone to myositis, a painful muscle condition causing spasms and cramps.
This information was contributed by Myristol.
Main Photo: Shutterstock/Catwalk Photos